spacer
spacer

PDBsum entry 5lhn

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/antibody PDB id
5lhn

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
238 a.a.
135 a.a.
Ligands
SO4 ×7
EDO ×2
Waters ×57
PDB id:
5lhn
Name: Hydrolase/antibody
Title: The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
Structure: Urokinase-type plasminogen activator. Chain: a. Synonym: upa. Engineered: yes. Mutation: yes. Camelid-derived antibody fragment nb7. Chain: b. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Gene: plau. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Vicugna pacos. Alpaca. Organism_taxid: 30538.
Resolution:
2.55Å     R-factor:   0.179     R-free:   0.219
Authors: T.Kromann-Hansen,E.L.Lange,H.P.Sorensen,G.H.Ghassabeh,M.Huang, J.K.Jensen,S.Muyldermans,P.Declerck,P.A.Andreasen
Key ref: T.Kromann-Hansen et al. (2017). Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator. Sci Rep, 7, 3385. PubMed id: 28611361
Date:
12-Jul-16     Release date:   28-Jun-17    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P06869  (UROK_MOUSE) -  Urokinase-type plasminogen activator from Mus musculus
Seq:
Struc:
433 a.a.
238 a.a.*
Protein chain
No UniProt id for this chain
Struc: 135 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chain A: E.C.3.4.21.73  - u-plasminogen activator.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.

 

 
Sci Rep 7:3385 (2017)
PubMed id: 28611361  
 
 
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.
T.Kromann-Hansen, E.Louise Lange, H.Peter Sørensen, G.Hassanzadeh-Ghassabeh, M.Huang, J.K.Jensen, S.Muyldermans, P.J.Declerck, E.A.Komives, P.A.Andreasen.
 
  ABSTRACT  
 
Although trypsin-like serine proteases have flexible surface-exposed loops and are known to adopt higher and lower activity conformations, structural determinants for the different conformations have remained largely obscure. The trypsin-like serine protease, urokinase-type plasminogen activator (uPA), is central in tissue remodeling processes and also strongly implicated in tumor metastasis. We solved five X-ray crystal structures of murine uPA (muPA) in the absence and presence of allosteric molecules and/or substrate-like molecules. The structure of unbound muPA revealed an unsuspected non-chymotrypsin-like protease conformation in which two β-strands in the core of the protease domain undergoes a major antiparallel-to-parallel conformational transition. We next isolated two anti-muPA nanobodies; an active-site binding nanobody and an allosteric nanobody. Crystal structures of the muPA:nanobody complexes and hydrogen-deuterium exchange mass spectrometry revealed molecular insights about molecular factors controlling the antiparallel-to-parallel equilibrium in muPA. Together with muPA activity assays, the data provide valuable insights into regulatory mechanisms and conformational flexibility of uPA and trypsin-like serine proteases in general.
 

 

spacer

spacer